The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion
Open accessAbstract
Importance: The mortality rate for individuals on the wait list for lung transplant is 15% to 25%, and still only 20% of lungs from multiorgan donors are used for lung transplant. The lung donor pool may be increased by assessing and reconditioning high-risk extended criteria donor lungs with ex vivo lung perfusion (EVLP), with similar short-term outcomes. Objective: To assess the long-term outcomes of transplant recipients of donor lungs treated with EVLP. Design, Setting, and Participants: This retrospective cohort single-center study was conducted from August 1, 2008, to February 28, 2017, among 706 recipients of donor lungs not undergoing EVLP and 230 recipients of donor lungs undergoing EVLP. Exposure: Donor lungs undergoing EVLP. Main Outcomes and Measures: The incidence of chronic lung allograft dysfunction and allograft survival during the 10-year EVLP era were the primary outcome measures. Secondary outcomes included donor characteristics, maximum predicted percentage of forced expiratory volume in 1 second, acute cellular rejection, and de novo donor-specific antibody development. Results: This study included 706 patients (311 women and 395 men; median age, 50 years [interquartile range, 34-61 years]) in the non-EVLP group and 230 patients (85 women and 145 men; median age, 46 years [interquartile range, 32-55 years]) in the EVLP group. The EVLP group donors had a significantly lower mean (SD) Pao2:fraction of inspired oxygen ratio than the non-EVLP group donors (348 [108] vs 422 [88] mm Hg; P < .001), higher prevalence of abnormal chest radiography results (135 of 230 [58.7%] vs 349 of 706 [49.4%]; P = .02), and higher proportion of smoking history (125 of 204 [61.3%] vs 322 of 650 [49.5%]; P = .007). More recipients in the EVLP group received single-lung transplants (62 of 230 [27.0%] vs 100 of 706 [14.2%]; P < .001). There was no significant difference in time to chronic lung allograft dysfunction between the EVLP and non-EVLP group (70% vs 72% at 3 years; 56% vs 56% at 5 years; and 53% vs 36% at 9 years; log-rank P = .68) or allograft survival between the EVLP and non-EVLP groups (73% vs 72% at 3 years; 62% vs 58% at 5 years; and 50% vs 44% at 9 years; log-rank P = .97) between the 2 groups. All secondary outcomes were similar between the 2 groups. Conclusions and Relevance: Since 2008, 230 of 936 lung transplants (24.6%) in the Toronto Lung Transplant Program were performed after EVLP assessment and treatment. Use of EVLP-treated lungs led to an increase in the number of patients undergoing transplantation, with comparable long-term outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chambers, D. C., Yusen, R. D., Cherikh, W. S., Goldfarb, S. B., Kucheryavaya, A. Y., Khusch, K., Levvey, B. J., Lund, L. H., Meiser, B., Rossano, J. W., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.07.016 · Cited by 1,045
Cited by
Survival in adult lung transplantation: where are we in 2020?
Bos, S., Vos, R., Van Raemdonck, D. E., & Verleden, G. M. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000753 · Cited by 281
Textbook Outcome: Definition and Analysis of a Novel Quality Measure in Lung Transplantation
Halpern, S. E., Moris, D., Gloria, J. N., Shaw, B. I., Haney, J. C., Klapper, J. A., Barbas, A. S., & Hartwig, M. G. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000004916 · Cited by 40
Twenty-year survival following lung transplantation
Miggins, J. J., Reul Jr, R. M., Barrett, S., Rana, A., Alnajar, A., Dunson, J., Shafii, A., Garcha, P., Goss, J., & Loor, G. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1414 · Cited by 8
Metadata
- Authors
- Divithotawela, C., Cypel, M., Martinu, T., Singer, L. G., Binnie, M., Chow, C.-W., Chaparro, C., Waddell, T. K., de Perrot, M., Pierre, A., Yasufuku, K., Yeung, J. C., Donahoe, L., Keshavjee, S., & Tikkanen, J. M.
- Venue
- JAMA Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 2019-12-01
- Volume
- 154
- Issue
- 12
- Pages
- 1143
- ISSN
- 2168-6254 (ISSN-L)
- OpenAlex
- W2979816623
- Cited by
- 171
- References
- 1
- FWCI
- 15.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion. https://app.cochat.ai/papers/10.1001/jamasurg.2019.4079
- The paper
- Divithotawela, C., Cypel, M., Martinu, T., Singer, L. G., Binnie, M., Chow, C.-W., Chaparro, C., Waddell, T. K., de Perrot, M., Pierre, A., Yasufuku, K., Yeung, J. C., Donahoe, L., Keshavjee, S., & Tikkanen, J. M. (2019). Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion. JAMA Surgery. https://doi.org/10.1001/jamasurg.2019.4079
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.